Instead of making identical copies of the weight loss drugs, Empower and other compounders combine a GLP-1, either semaglutide or tirzepatide, with vitamin B12, change the dosage strength, or offer different delivery methods
GLP-1 medications have produced average losses of 10 to 22% of body weight in trials
Dr Knudsen and fellow scientists followed them for seven years and four months and found that people using these drugs over a long period of time had a lower risk of developing dementia
However, considering that the dose and time of administration may affect the killing efficiency and the recurrence of different cancer cells by radiotherapy, further research through in vivo and in vitro experiments is necessary
Know that it is not your fault and that gaining weight is a normal part of life
As a manufacturer observing other companies in the industry, I can see that Indigos business model is strongly centered around accessibility